Lyon-based Brenus Pharma raises €22.2 million for precision cancer vaccines
Brenus Pharma, a French biotech company specializing in the development of cancer vaccines, announced the completion of a €22.2 million Series A financing round. The round is led by Angelor, an investment fund bringing together a cluster of investors from …